What are the predictive factors in the risk and severity of chemotherapy-induced gastrointestinal toxicity?
Discipline of Anatomy & Pathology, School of Medicine, University of Adelaide, Adelaide SA 5005, Australia.
Rachel J
RJ
Gibson
Discipline of Physiology, School of Medicine, University of Adelaide, Adelaide SA 5005, Australia.
Joanne M
JM
Bowen
Discipline of Pharmacology, School of Medicine, University of Adelaide, Adelaide SA 5005, Australia.
Janet K
JK
Coller
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D015415:Biomarkers; D016207:Cytokines / Q000378:metabolism; D005767:Gastrointestinal Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism*; D014644:Genetic Variation; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy; D011379:Prognosis; D012306:Risk; D012720:Severity of Illness Index; D015398:Signal Transduction / Q000187:drug effects; D051197:Toll-Like Receptor 4 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism
D015415:Biomarkers; D016207:Cytokines; D018836:Inflammation Mediators; D051197:Toll-Like Receptor 4
TLR; chemotherapy; gastrointestinal toxicity; proinflammatory cytokines